In vitro activity of BAY v 3522, a new cephalosporin for oral administration.

The activity of BAY v 3522 was tested against over 500 clinical bacterial isolates and compared with the activities of ampicillin, amoxicillin-clavulanate, cefaclor, cefixime, cefuroxime, cephalexin, and/or ciprofloxacin, erythromycin, and metronidazole. BAY v 3522 activity against staphylococci and...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Hodges, T L, Eliopoulos, G M, Klimm, K, Moellering, R C
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1990
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171947/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2285305/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.9.1849
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!